Not available
Quote | Paramount Group Inc. (NYSE:PGRE)
Last: | $5.1375 |
---|---|
Change Percent: | -1.2% |
Open: | $5.18 |
Close: | $5.20 |
High: | $5.2 |
Low: | $5.115 |
Volume: | 183,963 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Paramount Group Inc. (NYSE:PGRE)
Paramount Group, Inc. (NYSE: PGRE) (“Paramount” or the “Company”) announced today that it will file its quarterly report on Form 10-Q for the quarter ended June 30, 2024 with the U.S. Securities and Exchange Commission and release its second quarter 2024 financial resu...
2024-05-05 09:00:00 ET Summary U.S. equity markets advanced for a second week while benchmark interest rates retreated from five-month highs after a critical slate of employment data showed a long-awaited cooldown in hiring trends. Foreshadowed by "dovish" remarks from Fed Chair P...
Message Board Posts | Paramount Group Inc. (NYSE:PGRE)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Paramount Group, Inc. (NYSE: PGRE) (“Paramount” or the “Company”) announced today that it will file its quarterly report on Form 10-Q for the quarter ended June 30, 2024 with the U.S. Securities and Exchange Commission and release its second quarter 2024 financial resu...
– Raises Guidance for Full Year 2024 – Paramount Group, Inc. (NYSE: PGRE) (“Paramount” or the “Company”) filed its Quarterly Report on Form 10-Q for the quarter ended March 31, 2024 today and reported results for the first quarter ended March 31...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...